Erste Asset Management GmbH purchased a new stake in The Allstate Co. (NYSE:ALL – Free Report) during the 3rd quarter, Holdings Channel.com reports. The fund purchased 53,253 shares of the insurance provider’s stock, valued at approximately $10,031,000.
A number of other hedge funds also recently made changes to their positions in ALL. Allspring Global Investments Holdings LLC raised its position in Allstate by 18.7% in the third quarter. Allspring Global Investments Holdings LLC now owns 3,000,866 shares of the insurance provider’s stock worth $569,114,000 after purchasing an additional 472,040 shares in the last quarter. Raymond James & Associates grew its stake in shares of Allstate by 10.6% in the 3rd quarter. Raymond James & Associates now owns 1,517,800 shares of the insurance provider’s stock valued at $287,851,000 after purchasing an additional 145,986 shares during the period. Dimensional Fund Advisors LP raised its holdings in shares of Allstate by 3.4% in the 2nd quarter. Dimensional Fund Advisors LP now owns 1,437,688 shares of the insurance provider’s stock worth $229,545,000 after buying an additional 47,038 shares in the last quarter. Pathway Financial Advisers LLC lifted its position in shares of Allstate by 18,472.5% during the 3rd quarter. Pathway Financial Advisers LLC now owns 1,052,687 shares of the insurance provider’s stock worth $199,642,000 after buying an additional 1,047,019 shares during the period. Finally, Hsbc Holdings PLC boosted its stake in Allstate by 3.3% in the 2nd quarter. Hsbc Holdings PLC now owns 1,007,953 shares of the insurance provider’s stock valued at $160,948,000 after buying an additional 31,789 shares in the last quarter. Institutional investors and hedge funds own 76.47% of the company’s stock.
Allstate Price Performance
Shares of ALL stock opened at $207.39 on Monday. The firm’s 50 day moving average price is $193.02 and its two-hundred day moving average price is $179.19. The stock has a market cap of $54.92 billion, a PE ratio of 13.43, a PEG ratio of 1.82 and a beta of 0.48. The Allstate Co. has a 52-week low of $134.17 and a 52-week high of $209.88. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.40 and a current ratio of 0.40.
Allstate Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Thursday, January 2nd. Stockholders of record on Friday, November 29th will be given a dividend of $0.92 per share. The ex-dividend date is Friday, November 29th. This represents a $3.68 annualized dividend and a dividend yield of 1.77%. Allstate’s payout ratio is currently 23.83%.
Insider Activity
In other Allstate news, insider John E. Dugenske sold 36,367 shares of the company’s stock in a transaction that occurred on Friday, September 20th. The shares were sold at an average price of $191.38, for a total value of $6,959,916.46. Following the completion of the sale, the insider now owns 27,364 shares of the company’s stock, valued at approximately $5,236,922.32. This represents a 57.06 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 1.80% of the stock is currently owned by company insiders.
Analyst Upgrades and Downgrades
A number of research analysts have issued reports on the company. BMO Capital Markets lifted their price objective on Allstate from $205.00 to $214.00 and gave the company an “outperform” rating in a report on Friday, October 18th. StockNews.com cut shares of Allstate from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, August 21st. Bank of America lifted their target price on shares of Allstate from $216.00 to $233.00 and gave the company a “buy” rating in a research note on Friday, October 18th. Wells Fargo & Company raised their price target on Allstate from $175.00 to $186.00 and gave the company an “equal weight” rating in a report on Tuesday, November 5th. Finally, JPMorgan Chase & Co. boosted their price objective on Allstate from $205.00 to $207.00 and gave the stock an “overweight” rating in a research note on Thursday, October 10th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $217.19.
Check Out Our Latest Research Report on Allstate
Allstate Profile
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Featured Stories
- Five stocks we like better than Allstate
- 3 Best Fintech Stocks for a Portfolio Boost
- Analog Devices: Why the Uptrend Could Accelerate in 2025
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Texas Pacific Land: Permian Basin Powerhouse With an AI Edge
- Technology Stocks Explained: Here’s What to Know About Tech
- ServiceNow: Will the High-Flyer Finally Split in 2024?
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Co. (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.